Recursion Pharmaceuticals, Inc. Class A Common Stock
RXRXRank #95Updated . Prices are snapshots and may be delayed.
Recursion Pharmaceuticals, Inc. Class A Common Stock price chart
AI Outlook for Recursion Pharmaceuticals, Inc. Class A Common Stock
Neutral posture- Long-term trend+1.0% vs 200-day average
- Medium-term trend-1.0% vs 50-day average
- Averages50-day above 200-day
- 3 more trend and momentum checks
- Nearby support and resistance levels
- What would strengthen or weaken the picture
Posture describes where the price stands today, from its own trend and momentum. It is not a forecast, a price target or financial advice. How it is worked out
Recursion Pharmaceuticals, Inc. Class A Common Stock performance
About Recursion Pharmaceuticals, Inc. Class A Common Stock
Recursion Pharmaceuticals, Inc. Class A Common Stock is a biotechnology company based in the United States, listed on NASDAQ since 2021 (ticker RXRX).
Its market capitalisation is $2.2 billion, the #95 largest of the 124 stocks Air Radar has market-cap data for.
Recursion Pharmaceuticals, Inc. Class A Common Stock market data
What is the price of Recursion Pharmaceuticals, Inc. Class A Common Stock today?
Recursion Pharmaceuticals, Inc. Class A Common Stock (RXRX) is at $3.47, −15.69% on the day.
What is the 52-week range of Recursion Pharmaceuticals, Inc. Class A Common Stock?
Over the past year Recursion Pharmaceuticals, Inc. Class A Common Stock has traded between $2.77 and $7.18. It is currently 16% of the way up that range.
What is the market cap of Recursion Pharmaceuticals, Inc. Class A Common Stock?
Recursion Pharmaceuticals, Inc. Class A Common Stock has a market capitalisation of $2,150,447,059, the #95 largest of the stocks Air Radar has market-cap data for.
Similar stocks
Prices are snapshots from market data providers and may be delayed. This page is for information only and is not investment advice.